相关实验视频
Updated: May 24, 2025

09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
29.4K
地中海饮食和乳腺癌:一个叙事性回顾
Claudia Reytor-González1, Ana Karina Zambrano2, Evelyn Frias-Toral3
1Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito 170527, Ecuado.
Medwave
|March 4, 2025
概括
地中海饮食可以降低乳腺癌风险,改善患者的生活质量. 坚持这种饮食显示了乳腺癌预防和管理的潜力,提供抗炎和抗氧化剂的好处.
科学领域:
- 在瘤学瘤学.
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 乳腺癌是全球女性癌症死亡的主要原因.
- 饮食习惯越来越被认为是乳腺癌发展和进展的重要因素.
- 风险因素包括年龄,遗传,肥胖和生活方式选择.
研究的目的:
- 综合审查关于地中海饮食在乳腺癌中的作用的文献.
- 了解它对乳腺癌发展和患者管理的影响.
- 探索其对预防和生活质量的潜在益处.
主要方法:
- 关于地中海饮食和乳腺癌现有研究的文献综述.
- 分析调查饮食对炎症,氧化应激,基因调节,激素和肠道微生物群的影响的研究.
- 综合有关降低风险,症状管理和死亡率的证据.
主要成果:
- 地中海饮食表现出抗炎和抗氧化特性.
- 它可能会影响基因表达,荷尔蒙平衡和肠道微生物群组成.
- 更高的坚持与降低乳腺癌风险和改善患者的治疗结果有关,包括生活质量和生存率.
结论:
- 地中海饮食在预防和治疗乳腺癌方面具有显著的潜力.
- 它对生物通路的抗炎,抗氧化和调节作用有助于这些益处.
- 需要进一步的研究来阐明机制,并确认公共卫生策略的临床影响.
相关概念视频
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer Survival Analysis
319
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
319
Cancer
47.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.4K
Hazard Ratio
76
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
76
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K

